Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Parthu Avvaru
Phosphatidylinositol 3-Kinase (PI3K) Inhibitors as Cancer Therapeutics
Journal of Hematology and Oncology
Cancer Research
Oncology
Hematology
Molecular Biology
Related publications
Phosphatidylinositol 3-Kinase Inhibitors Are a Triple Threat to Ovarian Cancer
Clinical Cancer Research
Cancer Research
Oncology
Treating Cancer With Phosphatidylinositol-3-Kinase Inhibitors: Increasing Efficacy and Overcoming Resistance
Journal of Lipid Research
Biochemistry
Endocrinology
Cell Biology
Heterogeneity of Phosphatidylinositol-3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin Activation in Cancer: Is PI3K Isoform Specificity Important?
Frontiers in Oncology
Cancer Research
Oncology
Histone Deacetylase Inhibitors as Cancer Therapeutics
Annals of Translational Medicine
Medicine
Phosphatidylinositol-3-Kinase (PI3K)/Akt Signaling Is Functionally Essential in Myxoid Liposarcoma
Molecular Cancer Therapeutics
Cancer Research
Oncology
Clinical Development of Phosphatidylinositol 3-Kinase Inhibitors for Non-Hodgkin Lymphoma
Biomarker Research
Biochemistry
Molecular Medicine
Clinical Biochemistry
Phosphatidylinositol-3-Kinase Pathway
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
The Phosphatidylinositol 3-Kinase Pathway as a Potential Therapeutic Target in Bladder Cancer
Clinical Cancer Research
Cancer Research
Oncology
Phosphatidylinositol 3-Kinase and Antiestrogen Resistance in Breast Cancer
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology